Notable Labs Inc. (NTBL) Total Debt to Capital

This chart illustrates that the current market value of the total debt-to-equity ratio for Notable Labs, Ltd. (NTBL) on the GURU.Markets platform is 0.00. The business relies on AI-driven predictive diagnostic services, where centralized data processing ensures high profitability. The development of personalized treatment regimens for blood cancer is attracting major pharmaceutical partners; however, a narrow specialization in early-stage development makes the model sensitive to binary trial outcomes.

Analyzing leverage is critical for balancing asset quality and business valuation, as the total liabilities-to-equity ratio determines the company's degree of financial dependence on borrowed funds. In the case of Notable Labs, Ltd. (NTBL), where the commercialization of its oncology platform requires long-term investment, changes in the proportion of total debt to equity reflect either the risk of underfunding or an excessive debt load during periods of regulatory review.